|
× |
 |
The Maudsley Staging Method for Treatment-Resistant Depression: Prediction of Longer-Term Outcome and Persistence of Symptoms PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Double-Blind Comparison of Olanzapine Versus Risperidone in the Acute Treatment of Dementia- Related Behavioral Disturbances in Extended Care Facilities PDF |
$40.00 |
|
$40.00 |
|
× |
|
Characteristics of Children With Elevated Symptoms of Mania: The Longitudinal Assessment of Manic Symptoms (LAMS) Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Intramuscular Ziprasidone, 2 mg Versus 10 mg, in the Short-Term Management of Agitated Psychotic Patients PDF |
$40.00 |
|
$40.00 |
|
× |
|
Can We Really Accelerate and Enhance the Selective Serotonin Reuptake Inhibitor Antidepressant Effect? A Randomized Clinical Trial and a Meta-Analysis of Pindolol in Nonresistant Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Does Varenicline Worsen Psychiatric Symptoms in Patients With Schizophrenia or Schizoaffective Disorder? A Review of Published Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Is Flunarizine a Long-Acting Oral Atypical Antipsychotic? A Randomized Clinical Trial Versus Haloperidol for the Treatment of Schizophrenia PDF |
$40.00 |
|
$40.00 |
|
× |
|
The History and Current State of Antidepressant Clinical Trial Design: A Call to Action for Proof-of-Concept Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Oral Administration of S-Adenosylmethionine (SAMe) and Lactobacillus Plantarum HEAL9 Improves the Mild-To-Moderate Symptoms of Depression: A Randomized, Double-Blind, Placebo-Controlled Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Open-Label Study of Atypical Neuroleptic Quetiapine for Treatment of Borderline Personality Disorder: Impulsivity as Main Target PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System PDF |
$40.00 |
|
$40.00 |
|
|
